The most clinically relevant pharmacological property affecting potential drug interactions is semaglutide's effect on gastric emptying
Lilly announced that ATTAIN-3 was the third successful Phase 3 trial, triggering global regulatory submissions for obesity in 2025
Sign up for the Bodywork newsletter
The Reason: Semaglutide provides biological appetite suppression, whereas intermittent fasting relies on behavioral discipline to manage hunger, which often leads to "overcompensation" (eating too much) during the feeding window
2.4 Serum ALT and AST, and hepatic MDA, reduced GSH and TG analysis Serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were examined by an automatic blood chemistry analyzer in Department of Clinical Laboratory from The Third Affiliated Hospital of Sun Yat-sen University (Xu et al., 2024)
And remember to moisturise well to keep your skin happy and hydrated